David Maximilian Erren

Mr. David Maximilian Erren


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DEDavid Maximilian Erren
David Maximilian Erren
FMFranziska Meister
Franziska Meister
KGKarsten Große
Karsten Große
Tony BrunsTony Bruns
Tony Bruns
NGNaomi Gestels
Naomi Gestels
IAIakovos Amygdalos
Iakovos Amygdalos
Background/Objectives: Recipient-related factors continue to influence long-term outcomes after deceased-donor liver transplantation (DDLT). This study evaluated the prognostic value of the preoperative C-reactive protein-to-albumin ratio (CAR) for recipient survival (RS) and graft survival (GS). Methods: Adult patients undergoing DDLT between 2010 and 2023 were retrospectively analyzed. Re-transplantations, split or domino transplants, patients who died within 90 days and patients with early allograft dysfunction were excluded. Primary endpoints were 3-year RS and GS. Receiver operating characteristic analysis was used to determine the optimal CAR cut-off. Survival was assessed using Kaplan–Meier analysis and Cox regression. Results: A total of 330 patients were included. Mean RS and GS were 112 months (95%CI 106–119) and 110 months (95%CI 103–116), respectively. Preoperative CAR demonstrated the strongest predictive value for 3-year RS (AUC = 0.70, p < 0.001) and GS (AUC = 0.71, p < 0.001). A CAR cut-off of 41% provided optimal discrimination. Patients with CAR > 41% had significantly reduced 3-year RS (31 vs. 34 months, p < 0.001) and GS (30 vs. 34 months, p < 0.001). CAR > 41% was independently associated with increased risk of 3-year mortality (HR 2.101, 95%CI 1.277–3.456, p = 0.003) and graft loss (HR 3.666, 95%CI 1.804–7.449, p < 0.001). Similar results were observed for 5-year outcomes. Conclusions: Elevated preoperative CAR is independently associated with inferior patient and graft survival and may enhance risk stratification after DDLT.